Biochemistry and Biophysics Reports· 2026Q2
AAV8-mediated CasRx delivery and expression in the cochlea and cochlear nucleus of mice
- 0citations
- Q2SCImago
- 2026year
Short summary
AAV8 successfully delivered and expressed CasRx RNA editor in mouse cochleae and cochlear nucleus, with no observed negative effects on neuronal morphology or hearing thresholds two weeks post-injection.
AI-generated from the title and abstract; the full text is not read.
Key points
- AAV8 vector successfully mediated CasRx expression in mouse cochleae and cochlear nucleus.
- No adverse effects on neuronal number or morphology were observed in the cochlear nucleus two weeks post-injection.
- Hearing performance, measured by ABR thresholds, remained normal, indicating the safety of RNA editing.
- This is the first demonstration of AAV-CasRx mediated RNA editing in the mouse cochlear nucleus.
AI-generated from the title and abstract; the full text is not read.
Abstract
CRISPR/Cas9 based gene editing has made great strides in recent years, enabling the treatment of a wide range of genetic diseases, including hearing loss in congenitally deaf mice. While current successful cases of gene editing for hereditary deafness might induce off-target mutations in DNA sequences，restricting to clinical translational application. CasRx, a recently discovered member of the type VI CRISPR system, only modifies the expression of target RNA without affecting the DNA to avoid off-target mutations resulting from gene editing, holding broad application prospects. Here, we used AAV8 to successfully mediated CasRx expression in the cochleae and cochlear nucleus of C57BL/6J mice. Two weeks after viral injection, it remained normal for the number and morphology of neurons and other types of cells in the cochlear nucleus. Importantly, the hearing performance measured in ABR thresholds also remained normal after viral injection, indicating the safety of RNA editing in the cochleae and cochlear nucleus. In conclusion, we firstly accomplished AAV-CasRx mediated RNA editing in cochlear nucleus of mice, proving safe for treatment of cochlear nucleus related diseases such as tinnitus and hearing loss.
The authors' abstract, as published at the source. Biochemistry and Biophysics Reports, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Sensory Systems
Sensory SystemsNeuroscience